摘要
结外NK/T细胞淋巴瘤(ENKTCL)是一种高度侵袭性的非霍奇金淋巴瘤(NHL),死亡率高。ENKTCL主要发生在亚洲、拉丁美洲等地区,中国、日本、韩国是该肿瘤的高发国家。EB病毒(EBV)感染与ENKTCL的发病密切相关,但导致其发病的具体分子机制尚不清楚。我国是ENKTCL的高发国家,有着丰富的病例资源,我国学者在探索ENKTCL的发病机制、治疗方法等方面做出了重要贡献,文章就近年来ENKTCL分子机制研究进展进行综述。
Extranodal nature killer/T cell lymphoma (ENKTCL) is a highly aggressive non-Hodgkin lymphoma (NHL) with a high mortality. ENKTCL is epidemic in Asia and Latin America, especially in China, Japan and South Korea. EBV has been proved to be associated closely with ENKTCL; however, specific molecular mechanism which can explain how the neoplasm develops is still unclear. Chinese population seems to be more susceptible to this lymphoma and Chinese scientists have made great contributions to thepathogenesis and the treatments of ENKTCL. This review mainly introduces the recent progress of molecular pathogenesis of ENKTCL.
作者
尹文娟
吴梅娟
Yin Wenjuan;Wu Meijuan(Department of Pathology,Zhejiang Cancer Hospital,Hangzhou 310022,China;Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province,Hangzhou 310022,China)
出处
《白血病.淋巴瘤》
CAS
2018年第9期570-573,共4页
Journal of Leukemia & Lymphoma
基金
浙江省医药卫生科技项目面上项目(2018245519)
关键词
淋巴瘤
结外NK-T细胞
分子机制
Lymphoma
extranodal NK-T-cells
Molecular pathogenesis